Skip to content
Study details
Enrolling now

Mind Body Intervention for Long COVID-19

Beth Israel Deaconess Medical Center
NCT IDNCT06045338ClinicalTrials.gov data as of Apr 2026
Target enrollment

180

Study length

about 2.2 years

Ages

18–65

Locations

1 site in MA

About this study

This trial is testing if a mind-body intervention can help people with symptoms of Long COVID. It involves comparing the effectiveness of this type of treatment to usual care and another active mind body intervention in reducing symptoms and improving daily functioning.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Participate in Mind Body Intervention #1
Primary goalSomatic Symptom Score-8 (SSS-8)

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low4%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Somatic Symptom Score-8 (SSS-8)

Secondary: Fatigue Severity Scale (FSS), Generalized Anxiety Disorder form 7 (GAD-7), Pain Anxiety Symptom Score-20 (Pass-20), Patient Reported Outcomes Measurement Information System Survey for Cognitive Function (PROMIS SF v2.0 cognitive function 8a), Patient Reported Outcomes Measurement Information System survey for function disability (PROMIS), Short Form Brief Pain Inventory (BPI)

Body systems

Infectious